Evidence map›Paper›PMID 28449721›Full record

Trial reportImplementation science : IS2017

Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).

Alexandra Prados-Torres, Isabel Del Cura-González, Daniel Prados-Torres, Juan A López-Rodríguez, Francisca Leiva-Fernández, Amaia Calderón-Larrañaga, Fernando López-Verde, Luis A Gimeno-Feliu, Esperanza Escortell-Mayor, Victoria Pico-Soler and 15 more

Registry-linked trialOpen access · goldAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Implementation science : IS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02866799 (Effectiveness of an Intervention for Improving Drug Prescription in Primary Care Patients With Multimorbidity and Polypharmacy), which is not on this map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02866799 nacompletednot on this map

Effectiveness of an Intervention for Improving Drug Prescription in Primary Care Patients With Multimorbidity and Polypharmacy: Study Protocol of a Cluster Randomized Clinical Trial (Multi-PAP Project)

TypeinterventionalSponsorInstituto Aragones de Ciencias de la SaludRan2016 to 2018Enrolled593ConditionsMultimorbidity, Polypharmacy, Other Diagnoses, Comorbidities, and ComplicationsArmsMulti-PAP, Usual care
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Multimorbidity Patterns in the General Population: Results from the EpiChron Cohort Study.International journal of environmental research and public health · 2020
    Article
  15. Article
  16. Article
  17. Observational
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 6 countries.

Alexandra Prados-TorresInstituto Aragonés de Ciencias de la Salud (IACS), IIS Aragón, Hospital Universitario Miguel Servet, Paseo Isabel La Católica 1-3, 50009, Zaragoza, Spain. sprados.iacs@aragon.es.
Isabel Del Cura-GonzálezRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
Daniel Prados-TorresUnidad Docente Multiprofesional de Atención Familiar y Comunitaria de Distrito Málaga/Guadalhorce, Málaga, Spain.
Juan A López-RodríguezRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
Francisca Leiva-FernándezUnidad Docente Multiprofesional de Atención Familiar y Comunitaria de Distrito Málaga/Guadalhorce, Málaga, Spain.
Amaia Calderón-LarrañagaInstituto Aragonés de Ciencias de la Salud (IACS), IIS Aragón, Hospital Universitario Miguel Servet, Paseo Isabel La Católica 1-3, 50009, Zaragoza, Spain.
Fernando López-VerdeCentro de Salud las Delicias, Distrito Sanitario Málaga/Guadalhorce, Málaga, Spain.
Luis A Gimeno-FeliuDepartamento de Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza, Zaragoza, Spain.
Esperanza Escortell-MayorRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
Victoria Pico-SolerRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
Teresa Sanz-CuestaRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
Mª Josefa Bujalance-ZafraCentro de Salud la Victoria, Distrito Sanitario Málaga/Guadalhorce, Málaga, Spain.
Mariel Morey-MontalvoRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
José Ramón Boxó-CifuentesCentro de Salud Puerta Blanca, Distrito Sanitario Málaga/Guadalhorce, Málaga, Spain.
Beatriz Poblador-PlouInstituto Aragonés de Ciencias de la Salud (IACS), IIS Aragón, Hospital Universitario Miguel Servet, Paseo Isabel La Católica 1-3, 50009, Zaragoza, Spain.
José Manuel Fernández-ArqueroServicio de Farmacia de Atención Primaria, Distrito Sanitario Málaga/Guadalhorce, Málaga, Spain.
Francisca González-RubioRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
María D Ramiro-GonzálezServicio de Medicina Preventiva, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Carlos Coscollar-SantaliestraRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
Jesús Martín-FernándezRed de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) ISCIII, Madrid, Spain.
Mª Pilar Barnestein-FonsecaInstituto de Investigación Biomédica de Málaga (IBIMA), Distrito Sanitario Málaga/Guadalhorce, Málaga, Spain.
José María Valderas-MartínezUniversity of Exeter Medical School, Exeter, UK.
Alessandra MarengoniDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Christiane MuthInstitute of General Practice, Johann Wolfgang Goethe University, Frankfurt, Germany.
Multi-PAP Group
Instituto de Salud Carlos III · ESUniversidad de Zaragoza · ESUniversidad Rey Juan Carlos · ESGoethe University Frankfurt · DEHospital Universitario Miguel Servet · ESUniversity of Exeter · GBInstituto Aragonés de Ciencias de la Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultimorbidity is associated with negative effects both on people's health and on healthcare systems. A key problem linked to multimorbidity is polypharmacy, which in turn is associated with increased risk of partly preventable adverse effects, including mortality. The Ariadne principles describe a model of care based on a thorough assessment of diseases, treatments (and potential interactions), clinical status, context and preferences of patients with multimorbidity, with the aim of prioritizing and sharing realistic treatment goals that guide an individualized management. The aim of this study is to evaluate the effectiveness of a complex intervention that implements the Ariadne principles in a population of young-old patients with multimorbidity and polypharmacy. The intervention seeks to improve the appropriateness of prescribing in primary care (PC), as measured by the medication appropriateness index (MAI) score at 6 and 12 months, as compared with usual care. METHODS/

designDesign: pragmatic cluster randomized clinical trial. Unit of randomization: family physician (FP). Unit of analysis: patient. SCOPE: PC health centres in three autonomous communities: Aragon, Madrid, and Andalusia (Spain). POPULATION: patients aged 65-74 years with multimorbidity (≥3 chronic diseases) and polypharmacy (≥5 drugs prescribed in ≥3 months). SAMPLE SIZE: n = 400 (200 per study arm).

interventioncomplex intervention based on the implementation of the Ariadne principles with two components: (1) FP training and (2) FP-patient interview. OUTCOMES: MAI score, health services use, quality of life (Euroqol 5D-5L), pharmacotherapy and adherence to treatment (Morisky-Green, Haynes-Sackett), and clinical and socio-demographic variables. STATISTICAL ANALYSIS: primary outcome is the difference in MAI score between T0 and T1 and corresponding 95% confidence interval. Adjustment for confounding factors will be performed by multilevel analysis. All analyses will be carried out in accordance with the intention-to-treat principle. DISCUSSION: It is essential to provide evidence concerning interventions on PC patients with polypharmacy and multimorbidity, conducted in the context of routine clinical practice, and involving young-old patients with significant potential for preventing negative health outcomes.

trial registrationClinicaltrials.gov, NCT02866799.

Indexed as

AgedAged, 80 and overChronic DiseaseDrug PrescriptionsFemaleHumansMaleMultimorbidityOutcome Assessment, Health CarePatient-Centered CarePolypharmacyPrimary Health CareSpain

Identifiers

PMID28449721
PMCPMC5406997
OpenAlexW2608280627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.